1. Sakshi, Mazumder R, Monika, et al. Novel approaches for allergen-specific immunotherapy—An overview. Trends in Immunotherapy 2023; 7(1): 2026. doi: 10.24294/ti.v7.i1.2026.

2. Zhang F, Lv Y, Zhou X, et al. Novel targeted cancer therapy based on β-hydroxybutyric acid associated energy metabolism regulated by intestinal flora. Trends in Immunotherapy 2023; 7(1): 2160. doi: 10.24294/ti.v7.i1.2160.

3. Pandey P, Khan F, Yadav K, et al. Screen natural terpenoids to identify potential Jab1 inhibitors for treating breast cancer. Trends in Immunotherapy 2023; 7(1): 2055. doi: 10.24294/ti.v7.i1.2055.

4. Sivalingam D, Singh M. Targeting the ACE2 receptor using nanomedicine: Novel approach to lung cancer therapy. Trends in Immunotherapy 2023; 7(1): 1838. doi: 10.24294/ti.v7.i1.1838.

5. Singh N, Mazumder R, Monika, et al. Development in therapeutic strategies for allergic conjunctivitis. Trends in Immunotherapy 2023; 7(1): 2025. doi: 10.24294/ti.v7.i1.2025.

6. Engin MMN, Özdemir Ö. Current mechanisms in the pathogenesis of lung fibrosis. Trends in Immunotherapy 2023; 7(1): 2028. doi: 10.24294/ti.v7.i1.2028.

7. Mohamed R, Ramli MM, Reshak AH, et al. Revolutionizing cancer treatment by boosting dendritic cell vaccine efficacy with graphene oxide. Trends in Immunotherapy 2023; 7(1): 2039. doi: 10.24294/ti.v7.i1.2039.

8. Takkella BK, Anusha NV, Sujanamulk B, et al. Perspective of 3D printing in dentistry—Exploring the new horizon. Trends in Immunotherapy 2023; 7(1): 2133. doi: 10.24294/ti.v7.i1.2133.

9. Shiva S, Khanzadeh S, Rashidi F, Lucke-Wold B. Association of anticardiolipin antibodies with epilepsy in children. Trends in Immunotherapy 2023; 7(1): 2021. doi: 10.24294/ti.v7.i1.2021.